Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900027184Phase 4Recruiting
Phase 4, open-label, single-arm trial of valproic acid in bipolar disorder (BD), sponsored by Jingzhou Mental Health Center. Primary endpoints: Valproate level and Blood progesterone level. Started Nov 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900027184.